Dupilumab Shown to Be Safe, Effective in Improving Bullous Pemphigoid Symptoms
This new data indicates that dupilumab in this patient population had favorable efficacy and safety, though some unique concerns were risk of infection and eosinophilia.
Meng Pan Shanghai Jiao Tong University School Of Medicine Department Of Dermatology At Rui Jin Hospital Rui Jin Hospital Shanghai Jiao Tong University School Bullous Pemphigoid Disease Area Index
Source: hcplive.com